Oligomeric amyloid-β targeted contrast agent for MRI evaluation of Alzheimer's disease mouse models. Alzforum, 21 Jun 2024 Park JW, Tian Y, Kim ST, Park C, Kim YM, Chung HK, Kim KM, Jahng GH. Front Pharmacol.